QT interval monitoring during clinical studies with mizolastine, a new H1 antihistamine-Reference-Cited by-同舟云学术

QT interval monitoring during clinical studies with mizolastine, a new H1 antihistamine

Published:1999-07 Issue: Volume:29 Page:206-211
ISSN:0954-7894
Container-title:Clinical & Experimental Allergy
language:en
Short-container-title:Clinical & Experimental Allergy

Author:

Delauche-Cavallier M. C.,Chaufour S.,Guérault E.,Lacroux A.,Murrieta M.,Wajman A.

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2222.1999.0290s3206.x/fullpdf

Reference20 articles.

1. Torsades de pointes occurring in association with terfenadine use;Monahan;J Am Med Assoc,1990

2. Rate-corrected QT interval: techniques and limitations;Funck-Brentano;Am J Cardiol,1993

3. Evaluation of 10 QT prediction formulas in 881 middle aged men from the seven countries study: emphasis on the cubic root Fridericia's equation;Puddu;J Electrocardiol,1988

4. Variability of QT measurement in healthy volunteeers with implications for selection of an abnormal QT value to predict drug toxicity and proarrhymthmia;Morganroth;Am J Cardiol,1991

5. Anti-inflammatory properties of mizolastine after oral administration on arachidonic acid-induced cutaneous reaction in the rat;Pichat;Arzn Forsch Drug Res,1998

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of allergy: Overview of synthetic anti-allergy small molecules in medicinal chemistry;European Journal of Medicinal Chemistry;2023-03

2. Structural and clinical impact of anti-allergy agents: An overview;Bioorganic Chemistry;2020-01

3. Cardiac safety of second‐generation H 1 ‐antihistamines when updosed in chronic spontaneous urticaria;Clinical & Experimental Allergy;2019-10-18

4. Cardiotoxicity of H1-antihistamines;Journal of Analytical & Pharmaceutical Research;2018-04-12

5. Cardiovascular safety of antihistamines;Advances in Dermatology and Allergology;2014